Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults
一项针对健康成年人的 I 期随机、评估者和受试者双盲、安慰剂对照研究,旨在评估通过 VX-103(一种 MIMIX 微针贴片 [MAP] 系统)递送的 H1N1 流感疫苗的安全性、反应原性、耐受性和免疫原性。
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0303450
Garg, Naveen; Tellier, Guy; Vale, Noah; Kluge, Jon; Portman, Jonathan L; Markowska, Anna; Tussey, Lynda